News: 26.06.2018 - Inthera Bioscience AG expands management team

< Inthera is tackling “undruggable” targets with innovative chemistry for the design of small molecule inhibitors of intracellular protein-protein interactions. The most advanced of these first-in-class therapeutics, an oral modulator of dysregulated transcription, is currently entering the preclinical stage. >

Inthera Bioscience AG / Einsiedlerstrasse 34 / CH-8820 Waedenswil

Inthera Bioscience AG
Einsiedlerstrasse 34, CH-8820 Waedenswil